Study of Awareness and Detection of Familial Hypercholesterolemia
Public ClinicalTrials.gov record NCT01960244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CASCADE FH Registry (CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia Registry)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The CASCADE-FH Registry is a national, multi-center initiative that will track the therapy, clinical outcomes, and patient-reported outcomes over time. The registry represents a collaboration between The Familial Hypercholesterolemia Foundation, the Duke Clinical Research Institute, lipid specialists, cardiologists, primary care providers, quality improvement personnel, and patients, all aiming to increase FH awareness, promote optimal disease management, and improve FH outcomes.
Study identification
- NCT ID
- NCT01960244
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 5,000 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2013
- Primary completion
- Nov 30, 2025
- Completion
- Nov 30, 2025
- Last update posted
- Nov 26, 2023
2013 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Center for Inherited Cardiovascular Diseases | Palo Alto | California | 94304 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Hypercholesterolemia trials
Other public records listing Hypercholesterolemia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07477704: A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia Recruiting
- NCT06451770: Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia Recruiting
- NCT06065098: Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health Active, not recruiting
- NCT00353782: Causes and Natural History of Dyslipidemias Recruiting
- NCT07447206: Vascular Intervention Strategies Trial for Alzheimer's Not yet recruiting
- NCT07514663: Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01960244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2023 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01960244 live on ClinicalTrials.gov.